文献速递中医内科

二氢丹参酮I靶向MIF抑制胃癌侵袭转移

Dihydrotanshinone I Targets MIF to Inhibit GSK‐3β/β‐Catenin Axis‐Mediated Invasion and Metastasis in Gastric Cancer
RSS 订阅 · Phytotherapy Research · 2026-10-28

本研究探讨二氢丹参酮I(DHT)抑制胃癌转移的分子机制。DHT直接结合MIF,恢复GSK-3β活性,促进β-catenin磷酸化降解,抑制EMT相关基因转录,从而抑制胃癌细胞侵袭转移;体内实验证实DHT抑制胃癌腹膜转移。

要点

  • DHT直接靶向MIF并抑制胃癌侵袭转移
  • DHT通过MIF/GSK-3β/β-catenin轴抑制EMT
  • 体内实验证实DHT抑制胃癌腹膜转移

核心结论

  • DHT通过直接结合MIF抑制GSK-3β/β-catenin轴介导的胃癌侵袭和转移。

研究设计与样本

  • 采用有限蛋白水解-质谱(LiP-MS)鉴定DHT直接结合靶点,并用表面等离子共振和分子对接验证。
  • 体内实验验证DHT对胃癌腹膜转移的抑制作用。

主要发现

  • DHT直接结合MIF,减弱AKT信号,恢复GSK-3β激酶活性。
  • 活化的GSK-3β促进β-catenin Ser33/37/Thr41磷酸化及蛋白酶体降解,抑制其核转位和EMT相关基因(如Snail和Twist)转录。
  • DHT最终抑制胃癌细胞上皮-间质转化(EMT)和转移潜能。
  • 体内实验证实DHT显著抑制胃癌腹膜转移。

临床怎么用

  • DHT可能通过靶向MIF/GSK-3β/β-catenin轴抑制胃癌转移,为丹参在癌症相关疾病中的民族药理学应用提供机制依据。
  • MIF可能作为预测DHT治疗反应的潜在生物标志物,但需未来临床验证。

局限性

  • MIF作为DHT治疗反应预测生物标志物的概念尚需未来临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

DHT directly binds to MIF and subsequently blunts AKT signaling, which restores the kinase activity of GSK-3β. The reactivated GSK-3β then promotes the phosphorylation (Ser33/37/Thr41) and proteasomal degradation of β-catenin, thereby preventing its nuclear translocation and inhibiting the transcription of EMT-related genes (e.g., Snail and Twist). Ultimately, this signaling cascade suppresses the epithelial-mesenchymal transition (EMT) and metastatic potential of gastric cancer cells. ABSTRACT Salvia miltiorrhiza Bunge has been a commonly used medicinal herb in China since ancient times, widely employed to treat blood stasis-related disorders, including cardiovascular and inflammatory diseases. Dihydrotanshinone I (DHT), a lipophilic diterpenoid derived from its roots, has demonstrated anti-tumor potential; however, its specific molecular mechanisms involved in gastric cancer (GC) metastasis remain a mystery. Here, we report that DHT significantly suppresses the invasion and metastasis of GC by directly targeting macrophage migration inhibitory factor (MIF). Using limited proteolysis-mass spectrometry (LiP–MS), we identified MIF as a direct binding target of DHT, which was further validated by surface plasmon resonance and molecular docking. Mechanistically, DHT binding to MIF restored GSK-3β activity, promoted β-catenin phosphorylation (Ser33/37/Thr41), and facilitated its proteasomal degradation, thereby inhibiting β-catenin nuclear translocation and transcription of epithelial–mesenchymal transition-related genes. In vivo experiments confirmed that DHT markedly suppressed peritoneal metastasis of GC. These findings not only elucidate a novel molecular axis—DHT/MIF/GSK-3β/β-catenin—in suppressing GC metastasis but also provide a mechanistic basis for the ethnopharmacological application of Danshen in cancer-related disorders. Furthermore, our findings raise the hypothesis that MIF might serve as a potential predictive biomarker for DHT treatment response in GC, a concept that warrants future clinical validation.

来源:Phytotherapy Research,查看原文。版权归原作者所有。

引用

  1. Phytotherapy Research:Dihydrotanshinone I Targets MIF to Inhibit GSK‐3β/β‐Catenin Axis‐Mediated Invasion and Metastasis in Gastric Cancer

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。